The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Unapproved therapeutic goods
There are a number of ways that patients can access therapeutic goods in Australia that have not been included in the Australian Register of Therapeutic Goods (ARTG). These goods are known as 'unapproved' goods.
Medicinal cannabis, vaping goods, MDMA and psilocybin
Latest alerts
-
We are aware of products being sold in Australia that claim to contain, or influence the levels of, nicotinamide adenine dinucleotide (NAD, NAD+, NADH) or nicotinamide mononucleotide (NMN) in the body.
-
Further examples of counterfeit Ozempic-labelled products have been detected and stopped at the Australian border.
-
Magnum XXL capsules pose a serious risk to your health and should not be taken.
Latest articles
-
Vacancies on advisory committees
We are seeking applications from professionals with relevant expertise in medicine and science, and consumers with relevant expertise in consumer perspectives and issues. -
Summit Pharmacy Pty Ltd issued infringement notices for the alleged unlawful manufacturing of medicinal cannabis products
We have issued 4 infringement notices totalling $75,120 to Queensland based pharmacy Summit Pharmacy Pty Ltd, for the alleged unlawful manufacturing of medicinal cannabis products. -
TGA seizes thousands of illicit vapes, nicotine pouches and therapeutic goods in Western Sydney
The Therapeutic Goods Administration (TGA) has seized more than 5,000 vapes, 7,000 nicotine pouches and other products across two locations in Sydney’s western suburb of Penrith.
Latest publications
-
Clarifies requirements for SAS and AP applications for healthcare practitioners to access Category 2, 3, 4 and/or 5 (i.e. Schedule 8) medicinal cannabis medicines for their patients under the age of 18 years (paediatric patients).